A nyelocsolaphámrák genetikai és molekuláris háttere és a génterápia lehetoségei

Translated title of the contribution: Genetic background of esophageal squamous cell carcinoma

Research output: Contribution to journalReview article

5 Citations (Scopus)


Esophageal cancer is the 9th most frequent malignancy. In more than 90% of all patients with esophageal cancer, the tumour is detected in an advanced stage. Surgery, conventional chemo- and radiotherapy are relatively ineffective. Gene therapy came into the limelight of interest. Authors discuss the genetics, molecular pathogenesis of esophageal squamous carcinoma. Clinical experience in connection with gene therapy of esophageal squamous cell carcinoma is discussed. Different targets include complementary nucleic acid treatment (antisense therapy), gene-replacement and importance of small interfering RNA-s.

Translated title of the contributionGenetic background of esophageal squamous cell carcinoma
Original languageHungarian
Pages (from-to)1795-1800
Number of pages6
JournalOrvosi hetilap
Issue number38
Publication statusPublished - Sep 23 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Genetic background of esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

  • Cite this